THC Therapeutics, Inc.
THCT
$0.0001
-$0.0002-66.67%
OTC PK
| 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | 04/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 118.29% | -815.20% | -89.97% | -134.85% | -94.40% |
| Total Depreciation and Amortization | -25.00% | 0.00% | 0.00% | 33.33% | -25.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -160.08% | 3,961.16% | 70.49% | 76.11% | 91.03% |
| Change in Net Operating Assets | -34.91% | -19.86% | 0.54% | -1.47% | -54.95% |
| Cash from Operations | -203.99% | -14,933.33% | -- | 100.00% | 96.43% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 42,650.00% | -33.33% | -- | -- | -100.00% |
| Total Debt Repaid | 100.00% | -- | -- | 100.00% | 81.41% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 176.54% | 16,100.00% | -- | 100.00% | -109.85% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -177.14% | -- | -- | 100.00% | -266.04% |